BPMC INVESTOR ALERT: Andrews & Springer LLC Investigates Blueprint Medicines Corporation


WILMINGTON, Del., May 23, 2024 (GLOBE NEWSWIRE) — Andrews & Springer LLC, a boutique Delaware law firm focused on representing shareholders, is investigating Blueprint Medicines Corporation (NASDAQ: BPMC) (“Blueprint Medicines” or the “Company”) for potential corporate misconduct.

If you currently own shares of Blueprint Medicines and want to receive additional information and protect your investments free of charge, please visit us at http://www.andrewsspringer.com/cases-investigations/blueprint-medicines-corporation/ or contact Craig J. Springer, Esq. at [email protected], or call toll free at 1-800-423-6013. You may also follow us on LinkedIn – www.linkedin.com/company/andrews-&-springer-llc, Twitter – www.twitter.com/AndrewsSpringer or Facebook – www.facebook.com/AndrewsSpringer for future updates.

Andrews & Springer is a boutique law firm representing shareholders nationwide who are victims of corporate misconduct. Among Andrews & Springer’s most recent successes include securing a $51 billion derivative recovery through complete rescission of Elon Musk’s $55 billion pay package in Tornetta v. Musk, et al., C.A. 2018-0408-KSJM. Having formerly defended some of the largest financial institutions in the world, our founding members use their valuable knowledge, experience, and superior skill for the sole purpose of achieving positive results for investors. For more information please visit our website at www.andrewsspringer.com.


Craig J. Springer
[email protected]
Toll Free: 1-800-423-6013

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. AfternoonHeadlines.com takes no editorial responsibility for the same.